Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 28;8(4):441-449.
doi: 10.15326/jcopdf.2021.0221.

Cytomegalovirus Seropositivity is Associated with Airflow Limitation in a Cohort of Veterans with a High Prevalence of Smoking

Robert Burkes  1   2 , Andrew Osterburg  1 , Timothy Hwalek  1 , Laura Lach  2 , Ralph J Panos  1   2 , Michael T Borchers  1   2
Affiliations

Cytomegalovirus Seropositivity is Associated with Airflow Limitation in a Cohort of Veterans with a High Prevalence of Smoking

Robert Burkes et al. Chronic Obstr Pulm Dis. .

Abstract

Background: Cytomegalovirus (CMV) represents an understudied chronic infection, usually contracted early in life, that causes chronic immune system alterations which may contribute to airflow limitations in a cohort of veterans with a high prevalence of smoking. We studied 172 participants at-risk for and with airflow limitation with available CMV serology to assess the relationship between CMV infection and chronic obstructive pulmonary disease (COPD)-related outcomes.

Methods: The study cohort includes 172 veterans who are smokers with or at risk for the development of COPD. Clinical data were obtained by chart abstraction at enrollment. CMV affinity (ever-exposure) and avidity testing (length of exposure) were performed on plasma samples collected at enrollment. Bivariable and multivariable logistic regression was used to determine the relationship between both cytomegalovirus affinity and avidity and odds of prevalent airflow limitation (post-bronchodilator forced expiratory volume in 1 second to forced vital capacity ratio <0.70) at enrollment. In those with airflow limitation (n=84), bivariable and multivariable logistic regression was used to determine relationships between CMV serostatus and reported exacerbations of COPD over 2 years prior to enrollment.

Results: Positive CMV serostatus was independently associated with a 136% higher odds of airflow limitation (95% confidence interval 1.11-5.06, P=0.03) at enrollment. Neither CMV affinity nor avidity was associated with COPD exacerbations in the 2 years prior to enrollment.

Conclusions: CMV serostatus is independently associated with airflow limitation in a cohort of veterans who smoke. Investigation into the timing of infection and alterations in cellular immunity caused by chronic CMV infection and smoking-related airways disease-related outcomes is warranted.

Keywords: COPD; COPD outcomes; airflow limitation; cytomegalovirus; viral infections.

PubMed Disclaimer

Conflict of interest statement

RMB, AO, LL, TH have no competing interests. MTB receives grants from the National Institutes of Health (NIH) and the VA. RJP is a site principal investigator on NIH-funded studies and recently on a clinical trial funded by Sanofi.

Similar articles

See all similar articles

Cited by

References

    1. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet. 2004;364:709-721. doi: https://doi.org/10.1016/S0140-6736(04)16900-6 - PubMed
    1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, 2020 report. GOLD website. Published2020. AccessedMarch2021. https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-0...
    1. Brandsma C-A ,Van den Berge M,Hackett T-L ,Brusselle G,Timens W. Recent advances in chronic obstructive pulmonary disease pathogenesis: from disease mechanisms to precision medicine. J Pathol. 2020;250(5):624-635. doi: https://doi.org/10.1002/path.5364 - PMC - PubMed
    1. Wells JM,Xing D,Viera L,et al. The matrikine acetyl-proline-glycine-proline and clinical features of COPD: findings from SPIROMICS. Respir Res. 2019;20:254. doi: https://doi.org/10.1186/s12931-019-1230-8 - PMC - PubMed
    1. Burkes RM,Astemborski J,Lambert AA,et al. Plasma cathelicidin and longitudinal lung function in current and former smokers. PLoS One. 2019;14(2):e0212628. doi: https://doi.org/10.1371/journal.pone.0212628 - PMC - PubMed